Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TICTAC: Perioperative Formoterol Fumarate in Thoracic Surgery
NCT06865040Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Jul 2025
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of formoterol in postoperative pulmonary complications (PPC) (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Number of postoperative pulmonary complications at 7 days. Started Jul 2025; status: recruiting.
02
Drugs
formoterol
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT06865040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06865040.